Novel β-chain-targeting approach for the treatment of lymphoma [PreClinical] – 2 Minute Medicine
2 Minute Medicine |
Novel β-chain-targeting approach for the treatment of lymphoma [PreClinical]
2 Minute Medicine 1. The β-chain constant region of the T cell receptor (TCR) was targeted to specifically eliminate a population of malignant T cells. 2. Engineered chimeric antigen receptor (CAR) T cells with specificity to the β-chain constant region successfully … |
